Quantification of mRNA expression by competitive PCR using non-homologous competitors containing a shifted restriction site

Nucleic Acids Research

Volumn 29, Issue 11, 2020, Pages

  Watzinger, Franz ^a   Hörth, Elfriede ^a   Lion, Thomas ^a  

^a ST ANNA CHILDREN S HOSPITAL   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ADENINE; CYTOSINE; DNA; ENDONUCLEASE; GUANINE; MESSENGER RNA; THYMINE; COMPLEMENTARY DNA; GLYCOPROTEIN P; PRIMER DNA; RESTRICTION ENDONUCLEASE;

AMPLICON; ARTICLE; CONTROLLED STUDY; DNA DENATURATION; ELECTROPHORESIS; ENZYME DEGRADATION; GENE; GENE EXPRESSION; GENE SEQUENCE; IMAGE ANALYSIS; MOLECULAR CLONING; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION SITE; SHIFTED RESTRICTION SITE COMPETITIVE POLYMERASE CHAIN REACTION; BINDING SITE; GENETICS; HUMAN; METABOLISM; METHODOLOGY;

BINDING SITES; DNA PRIMERS; DNA RESTRICTION ENZYMES; DNA, COMPLEMENTARY; HUMANS; P-GLYCOPROTEIN; POLYMERASE CHAIN REACTION; RNA, MESSENGER;

MLCS; MLOWN;

EID: 0035378683     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/29.11.e52     Document Type: Article

References (29)

1. Gaiger, A., Henn, T., Hörth, E., Geissler, K., Mitterbauer, G., Maier-Dobersberger, T., Greinix, H., Mannhalter, C., Haas, O.A., Lechner, K. and Lion, T. (1995) Increase of bcr-abl chimeric mRNA expression in tumor cells of patients with chronic myeloid leukemia precedes disease progression. Blood, 86, 2371-2378.
2. Lion, T., Izraeli, S., Henn, T., Gaiger, A., Mor, W. and Gadner, H. (1992) Monitoring of residual disease in chronic myelogenous leukemia by quantitative polymerase chain reaction. Leukemia, 6, 495-499.
3. Vu, H.L., Troubetzkoy, S., Nguyen, H.H., Russell, M.W. and Mestecky, J. (2000) A method for quantification of absolute amounts of nucleic acids by (RT)-PCR and a new mathematical model for data analysis. Nucleic Acids Res., 28, e18.
4. Apostolakos, M.J., Schuermann, W.H., Frampton, M.W., Utell, M.J. and Willey, J.C. (1993) Measurement of gene expression by multiplex competitive polymerase chain reaction. Anal. Biochem., 213, 277-284.
5. Bolton, M.C., Dudhia, J. and Bayliss, M.T. (1996) Quantification of aggrecan and link-protein mRNA in human articular cartilage of different ages by competitive reverse transcriptase-PCR. Biochem. J., 319, 489-498.
6. Paschen, W. and Djuricic, B. (1995) Regional differences in the extent of RNA editing of the glutamate receptor subunits GluR2 and GluR6 in rat brain. J. Neurosci. Methods, 56, 21-29.
7. Wu, J., Sullivan, D.E. and Gerber, M.A. (1994) Quantitative polymerase chain reaction for hepatitis B virus DNA. J. Virol. Methods, 49, 331-341.
8. Colle, J.H., Falanga, P.B., Singer, M., Hevin, B. and Milon, G. (1997) Quantitation of messenger RNA by competitive RT-PCR: a simplified read out assay. J. Immunol. Methods, 210, 175-184.
9. Fandrey, J. and Bunn, H.F. (1993) In vivo and in vitro regulation of erythropoietin mRNA: measurement by competitive polymerase chain reaction. Blood, 81, 617-623.
10. Henley, W.N., Schuebel, K.E. and Nielsen, D.A. (1996) Limitations imposed by heteroduplex formation on quantitative RT-PCR. Biochem. Biophys. Res. Commun., 226, 113-117.
11. Mc Culloch, R.K., Choong, C.S. and Hurley, D.M. (1995) An evaluation of competitor type and size for use in the determination of mRNA by competitive PCR. PCR Methods Appl., 4, 219-226.
12. Serth, J., Panitz, F., Herrmann, H. and Alves, J. (1998) Single-tube nested competitive PCR with homologous competitor for quantitation of DNA target sequences: theoretical description of heteroduplex formation, evaluation of sensitivity, precision and linear range of themethod. Nucleic Acids Res., 26, 4401-4408.
13. Lu, Z., Douthitt, M.P., Taffs, R.E., Ran, Y., Norwood, L.P. andChumakov, K.M. (1993) Quantitative aspects of the mutant analysis by PCR and restriction enzyme cleavage (MAPREC). PCR Methods Appl., 3, 176-180.
14. Borkhardt, A., Repp, R., Harbott, J., Kreuder, J. and Lampert, F. (1993) Quantification of leukaemic cells based on heteroduplex formation of tal-1 gene sequences after PCR coamplification. Br. J. Haematol., 83, 39-44.
15. Becker-Andre, M. and Hahlbrock, K. (1989) Absolute mRNA quantification using the polymerase chain reaction (PCR). A novel approach by a PCR aided transcript titration assay (PATTY). Nucleic Acids Res., 17, 9437-9446.
16. Thielking, V., Alves, J., Fliess, A., Maass, G. and Pingoud, A. (1990) Accuracy of the EcoRI restriction endonuclease: binding and cleavage studies with oligodeoxynucleotide substrates containing degenerate recognition sequences. Biochemistry, 29, 4682-4691.
17. Kobayashi, H., Takemura, Y., Miyachi, H., Kawabata, M., Mori, S., Kawai, Y., Furihata, K., Sekiguchi, S. and Watanabe, K. (1997)Quantitative analysis of human multidrug resistance 1 (MDR1) gene expression by nonisotopic competitive reverse transcriptase polymerase chain reaction assay. J. Clin. Lab. Anal., 11, 258-266.
18. Sestini, R., Orlando, C., Zentilin, L., Lami, D., Gelmini, S., Pinzani, P., Giacca, M. and Pazzagli, M. (1995) Gene amplification for c-erbB-2, c-myc, epidermal growth factor receptor, int-2, and N-myc measured by quantitative PCR with a multiple competitor template. Clin. Chem., 41, 826-832.
19. Moravcova, J., Lukasova, M., Stary, J. and Haskovec, C. (1998) Simple competitive two-step RT-PCR assay to monitor minimal residual disease in CML patients after bone marrow transplantation. Leukemia, 12, 1303-1312.
20. van Rhee, F., Marks, D.I., Lin, F., Szydlo, R.M., Hochhaus, A., Treleaven, J., Delord, C., Cross, N.C. and Goldman, J.M. (1995) Quantification of residual disease in Philadelphia-positive acute lymphoblastic leukemia: comparison of blood and bone marrow. Leukemia, 9, 329-335.
21. Piatak, M., Luk, K.C., Williams, B. and Lifson, J.D. (1993) Quantitative competitive polymerase chain reaction for accurate quantitation of HIV DNA and RNA species. Biotechniques, 14, 70-81.
22. Hochhaus, A., Lin, F., Reiter, A., Skladny, H., Mason, P.J., van Rhee, F., Shepherd, P.C., Allan, N.C., Hehlmann, R., Goldman, J.M. and Cross, N.C. (1996) Quantification of residual disease in chronic myelogenous leukemia patients on interferon-α therapy by competitive polymerase chain reaction. Blood, 87, 1549-1555.
23. Watzinger, F. and Lion, T. (1998) Multiplex PCR for quality control of template RNA/cDNA in RT-PCR assays. Leukemia, 12, 1984-1986.
24. Lion, T. (2001) Current recommendations for positive controls in RT-PCR assays. Leukemia, 15, in press.
25. Eckert, C., Landt, O., Taube, T., Seeger, K., Beyermann, B., Proba, J. and Henze, G. (2000) Potential of Light Cycler technology for quantification of minimal residual disease in childhood acute lymphoblastic leukemia. Leukemia, 14, 316-323.
26. Emig, M., Saussele, S., Wittor, H., Weisser, A., Reiter, A., Willer, A., Berger, U., Hehlmann, R., Cross, N.C. and Hochhaus, A. (1999) Accurate and rapid analysis of residual disease in patients with CML using specific fluorescent hybridization probes for real time quantitative RT-PCR. Leukemia, 13, 1825-1832.
27. Nakao, M., Janssen, J.W., Flohr, T. and Bartram, C.R. (2000) Rapid and reliable quantification of minimal residual disease in acute lymphoblastic leukemia using rearranged immunoglobulin and T-cell receptor loci by Light Cycler technology. Cancer Res., 60, 3281-3289.
28. Wattjes, M.P., Krauter, J., Nagel, S., Heidenreich, O., Ganser, A. andHeil, G. (2000) Comparison of nested competitive RT-PCR and real-time RT-PCR for the detection and quantification of AML1/MTG8 fusion transcripts in t(8, 21) positive acute myelogenous leukemia. Leukemia, 14, 329-335.
29. Lion, T. (1996) Control genes in reverse transcriptase-poymerase chain reaction assays. Leukemia, 10, 1527-1528.